Dow Up 0.07% Nasdaq Up 0.61%

More On CMXI

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Nuo Therapeutics, Inc. (CMXI)

-Other OTC
0.34 Down 0.01(2.86%) Nov 13, 3:59PM EST
Prev Close:0.35
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:1.50
Beta:-1.53
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.34 - 0.68
Volume:0
Avg Vol (3m):283,862
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nuo Therapeutics, Inc., a biomedical company, provides biodynamic therapies for wound care. Its flagship product is the Aurix, a biodynamic hematogel that harnesses a patient's innate regenerative abilities for the management of various wounds. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback